Engineered adenovirus Ad5–3M with highlighted in red mutations that were introduced to target virus to tumor cells, reduce inflammation, and avoid interactions with blood factors and immune cells after systemic administration — Image Credit: Dmitry Shayakhmetov

ONCOLYTIC VIRUS

Modified oncolytic adenovirus can be an effective cancer-killing machine

Researchers have engineered an oncolytic virus to target the cancer cells by avoiding the body’s immune system

Now that the COVID-19 pandemic has shown us that cutthroat technology can be used to devise a vaccine in…